Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BS would be stealing my dream if he dilutes before the company gets a solid base
Just remember what happened the last time that the sp hit the mid-teens... ...don't be shy about taking profits along the way as there are still countless millions of deeply discounts stock lurking in the overhang ready to dump into the float as soon as a bona fide run shows itself. And in addition to the 0.00 shares and 0.05 PIPE shares, we now have the .06 Seaside shares, along with all the shares that retail investors have accumulated in the .08-.11 range that will be at-risk of getting flipped once the sp hits the mid-teens.
GLTA and remember to be nimble! The SCRC ATM will yield cash again at some point just as it had in the past -- and it will continue yo-yo'ing and yielding profits until the overhang of cheap shares flushes itself out. Folks can recognize this repeating pattern and profit from it or they can continue being bagholders while the sp inevitably retraces again, it's up to you...
And while we're on the subject, SeeThruEquity is also a paid shill. Legitimate conference organizers do not prostitute themselves out the way SeeThruEquity does via its service offerings as per their own website:
Press Release for Industry Report
$1,500 per release (per company in report)
SeeThruEquity prepares industry reports from time to time. If the subject companies in the report are interested in a press release on a major newswire service and dissemination of the press release, SeeThruEquity charges a fee of $1,500 per release per company. The press release will include quotes from SeeThruEquity management referencing the report and subject companies. The report will be also emailed to our opt-in database of investors.
Earnings Call Transcript Distribution
$1000 per call
A SeeThruEquity analyst will join one company quarterly conference call and ask questions on the call for the record. The call transcript will be emailed to our opt-in database of investors
CEO Interviews
$1,000 per interview
SeeThruEquity Analyst will interview Company CEO and prepare a 1-2 page transcript of the questions and answers. The transcript will be emailed to our opt-in database of investors
Press Release for Articles or Blogs
$1,750 per release
SeeThruEquity may write articles and blogs on smallcap and microcap companies. For a fee of $1,750, we will disseminate the information in a press release on a major newswire service with quotes from SeeThruEquity management, and reference the particular article or blog.
Press Release for Initiation of Coverage or Update Note
$1,500 per release
SeeThruEquity will issue a press release on a major newswire service with quotes from SeeThruEquity management upon initiation of coverage or an update note with approval from the company to link with the company’s headlines such as Yahoo! Finance ticker/headlines, Google Finance and other financial websites. The release and write up will also be sent to our opt-in database of investors.
www.seethruequity.com/#!a-la-carte/c10v4
In essence, for a fee, SeeThruEquity will write up a promo piece about your company and present it in the form of a PR or analyst report and include a quote from a SeeThruEquity exec specifically mentioning your company, and send it out to various media platforms.
$ 4.09M......JUL approved orders
$ 4.87M......AUG approved orders
$ 5.46M......SEP approved orders
$ 1.77M......JUN backlog shipped/recognized in JUL (so need to count as Q3 revenues)
-------------
$16.18M......BEST CASE SCENARIO FOR Q3 REVENUES, WHICH MEANS THERE IS ZERO BACKLOG AS OF 9/30/14
However, if the backlog is 20 days like it was as of 6/30/14, then 20 days worth of SEP approved orders comes out to appox $3.64M ($5.46M for SEP divided by 30 days = $182k/day; then multiply this daily rate by 20 days to get $3.64M). So if this 20-day backlog shows up again, then we need to deduct $3.64M fom the $16.18M and Q3 revenues would then instead be $12.54M.
Here is the presentation from their website that they will be giving today at the conference
scripsamerica.com/wp-content/uploads/2014/11/Presentation-November-2014-v2.pdf
Funny, I'm reading elsewhere that the company will post EPS but not to expect the PPS to rise too much or at all. Even with the conference tomorrow we are not to expect too much from it. I wonder if this is a veiled attempt to have people hold so that some dumping of cheap shares can occur?
That's what we call a core base company.
I don't understand your example. A million shares traded is a million shares traded regardless of the price share. After all this is a penny stock. A million shares for a penny stock trading at .10 is a lot considering this stock was trading pretty flat for a long time. Those shares moved the value of everyone's portfolios up.
A company that hires illegal promotion can never be legitimate IMO.
So why did Ironridge put out that PR the other day? What is the purpose?
The big test will be if listening to the scrc presentation are any credible microcap investors
Small Cap Report Link! Go SCRC! Tut
finance.yahoo.com/news/small-cap-traders-provides-brief-120000522.html
This lawsuit makes for good PR, but unless there is more to it that is currently not available in the public space, this will not end well for SCRC if the above arguments represent the centerpiece of their litigation strategy.
For once, he is at least posting actual "new" news and not repeatedly posting the same stale news.
The good... ...SCRC already disclosed in the Q2 10Q that it had accrued for this expense already, so losing this lawsuit should have no impact on the bottom line in Q3 or beyond.
The bad... ...the 1.6M shares that Ironridge was demanding will now be issued to IR and is apparently priced at .10/share, so this just adds even more cheap stock to the float, lurking in the overhang waiting to crater the sp back down when the sp rises to a price of their liking, which could begin anywhere in the mid-teens given IR's past history.
The good... ...this news hit the same day that the OCT Main Ave numbers were released, so hopefully it got glossed over by the market.
The bad... ...we will have to hold our breaths to see if BS Schneiderman was able to pursue this failed suit against IR at minimal cost to the bottom line. Upcoming Q will be an interesting read...
There is definitely a new regime and a different way of thinking with this company.
If you are selling guys, hold and get your price. We have another nice day going here. If you watch the trades, you'll see big share sizes on the ask. If you're selling, you have the control. Use it to your benefit. This whole run has been basically on the ask. Take advantage of this. It doesn't happen very often.
ScripsAmerica Reports $5.6 Million in Approved Orders for Its Specialty Pharmacy in October
I hope you are right about the new regulations having minimal impact Just the other day I think that held your #1 spot for concern. Perhaps not out of the woods yet.... but at least the signs seem to be pointing in the right direction.
We had it set up really well. Bids at .12 Asks at .125. Someone sells 22 shares at .1115 and everything crumbles. Unbelievable!!!!
That guy with the 22 shares has now de-risked
Meant to say green finish not green fish.
Now I feel like stupid fool.
I see what you did there [polite applause]...
Although I like having black shower curtains, you are right in that I should replace them -- especially considering that they started out white... ...but alas my beer and shower curtain money is tied up in DSS and the price action over the past many months have made me feel like I need a never-ending shower now that I am a resident of the seedy side of pennyland...
the wheels of justice turn ever so slowly
FYI for those who believe that the PR re: OCT "approved orders" for the Main Ave compounding pharmacy may be a catalyst, be advised that prior to this announcement, Seaside has another large tranche of almost 800k shares of .06 stock that is scheduled to unlock and become free-trading on 11/1/14. So be nimble if your objective is to take some profits before Seaside and the CORE PIPE-holders take them all.
I personally think that the OCT "approved orders" number is the single most important monthly PR SCRC will issue as it will represent the first complete month in the post-insurance restriction market for compounded Rx's. This is the first obstacle that SCRC needs to overcome.
The second obstacle, IMO, is to be able to report positive earnings for the first time in the upcoming Q3 10Q. As I have opined on several occassions previously, I believe SCRC should be able to do this.
The third obstacle, IMO, is to be able to report either flat or growing Main Ave "approved orders" during the month of JAN-2015 (to be reported in early-FEB), as 1/1/15 is the final conversion date for the largest employers to implement the new insurance coverage restrictions on compounded Rx's. So JAN-2015 represents the first full month of 100% employer/employee compliance with the new insurance coverage rules.
The fourth and final obstacle, IMO, is to be able to file an AUDITED (remember, the Q's during 2013 have all been UN-audited) 10K next APR-2015 that shows that not only are all the revenues and "approved orders" that have been previously PR'd and reported for Main Ave legit, BUT also that SCRC has applied the VIE accounting rules properly. Variable Interest Entity (VIE) accounting has been a growing hot-button issue in the marketplace over the past year and has caused heartburn to many retail investors as an increasing number of companies who assert that certain 3rd parties are VIE's and therefore qualify to have ALL of their numbers 100% consolidated together, are subsequently being told by their auditors that their VIE determination was improper -- and requiring the company to restate prior period financials effectively wiping out the lion's share of reported revenues. One recent example of this is EWSI. Not pretty. SCRC declaring Main Ave to be a VIE (via Implex) is what has enabled SCRC to claim ALL of Main Ave's revenues as its own even though SCRC does NOT own Main Ave and the only legal relationship w/Main Ave is that SCRC is supposed to only receive a monthly mgmt fee for running the ops of Main Ave.
If SCRC can demonstrate that its Main Ave revenues (not to mention United Apothecary and Jungle Jim's revenues) are NOT materially impacted by the new insurance coverage restrictions AND that it has properly applied the VIE rules, then I would be absolutely stunned if the market continued to treat SCRC as an unwanted stepchild. If SCRC overcomes these obstacles and still wallows in obscurity and sp purgatory, then I truly will have no idea what else the market could possible be scared of... ...well, I suppose the market will also want to see evidence in the daily historical tape that all the overhang has flushed thru and that the CORE PIPE-holders are no longer manipulating the sp, so let's call that "obstacle #5" (which, given BS Schneiderman's past behavior, this one may prove to be the most difficult obstacle of all to overcome)...
Form T Trade after hours, 241,000 shares @ $.0959 buy end of the day! = 510,000 buys and 80,860 sells & 11,325? = 602,685 total daily trades
I think many of the core investors are done and moved on... the lack of interest and silence about scrc at this point is a little starnge if not that
I guess all the unlocked cheapie shares are gone.
Looks like the loyal shareholders are going to be holding the bag here.
Nice volume today. One month out till the Q hits. Maybe we are seeing a miniature run-up?
10% owner Urbanski sold another 80,000 shares per the form 4 filed.
DILUTION UPDATE:
On 10/13/14, 370k more shares of .05 PIPE stock belonging to a CORE "investor" (LOL) unlocked and added itself to the already bloated overhang of deeply discounted shares lurking in the float. Depending on how quickly this flipper was able to get the cert cleared, these shares would have become free-trading either yesterday at the earliest or today or tomorrow. If no signs of liquidation, then we need to add it to the overhang as being yet even more shares that are simply waiting for the next pop in order to get dumped...
For a company with a $65M run rate, its clear the market and some holders don't believe Bob.
222200 on the ask at .092.Somebody is looking to bail.
However like most of you guys cant figure out why this stock stays at .09 cents...
CHP, Looking at the past and the run up and immediate drop in PPS due to the pump of Rapidmeds and stock promotions, with the silence of the last couple weeks do you think that there may have been a formal investigation into all thats went on here?
Interesting PR today re: SEP approved orders of $5.46M. As I stated in a prior post, what we have no visibility on is the breakdown of "pre-9/15" vs "post-9/15" approved orders. Hopefully it is evenly split as this would mean that Main Ave was minimally impacted by the new insurance coverage restrictions. However, if the lion's share of this $5.46M was pre-9/15 (i.e. a rush of orders and refills earlier in the month than usual in order to make it before the 9/15 kill-date), then this would paint a completely different story. We simply do not know at this point. This is why I have been stating that the next monthly PR in OCT will be critical.
That being said, if we just take the PR at face value for the time being, this means that Q3 looks like this:
$ 4.09M......JUL approved orders
$ 4.87M......AUG approved orders
$ 5.46M......SEP approved orders
$ 1.77M......JUN backlog shipped/recognized in JUL (so need to count as Q3 revenues)
-------------
$16.18M......BEST CASE SCENARIO FOR Q3 REVENUES, WHICH MEANS THERE IS ZERO BACKLOG AS OF 9/30/14
However, if the backlog is 20 days like it was as of 6/30/14, then 20 days worth of SEP approved orders comes out to appox $3.64M ($5.46M for SEP divided by 30 days = $182k/day; then multiply this daily rate by 20 days to get $3.64M). So if this 20-day backlog shows up again, then we need to deduct $3.64M fom the $16.18M and Q3 revenues would then instead be $12.54M.
Obviously, a smaller backlog would translate to Q3 revenues somewhere between $12.54M and $16.18M (due to a smaller adjustment for fewer days), and a larger backlog would result in Q3 revenues lower than $12.54M (due to a larger adjustment for additional days).
Hopefully, SCRC will discuss the impact of the new insurance restrictions in the Notes and MD&A sections of the upcoming Q; however, if history holds to form, we should get all the answers we need before 11/15/14 once the OCT approved orders are PR'd in early NOV.
I didn't say it was accurate although it would be nice if it was.
So, any bets on what the revenue number will be for Sept that they announce soon?
The market will yawn for just so long. Sooner or later the market will realize what a great company SCRC is.
Stay the course, it is just a matter of time.
Once the third and fourth quarters are reported things will change DRAMATICALLY to the UPSIDE.
Will we hit 5 million for SEPT.
If we do that will be another record month.
My money says the WINNING STREAK WILL CONTINUE.